IDEAYA Biosciences, Inc. Increase (Decrease) in Accounts Payable
IDEAYA Biosciences, Inc. (IDYA) reported Increase (Decrease) in Accounts Payable of $11.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $8.89M.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $3.05M, a 11.80% increase year-over-year.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$858.00K, a 128.83% decline year-over-year.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.19M.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2025 was $2.70M, a 67.43% decline from fiscal 2024.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2024 was $8.28M, a 214.23% increase from fiscal 2023.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2023 was $2.63M, a 41.36% increase from fiscal 2022.
- IDEAYA Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.86M, a 59.86% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.94M 10-Q · filed 2026-08-04 | $11.08M derived: sum of 3 quarters · filed 2026-08-04 | $12.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.05M 10-Q · filed 2026-05-05 | $2.19M derived: sum of 2 quarters · filed 2026-05-05 | $3.38M derived: sum of 3 quarters · filed 2026-05-05 | $3.02M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$858.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $333.00K derived: sum of 2 quarters · filed 2026-02-17 | -$31.00K derived: sum of 3 quarters · filed 2026-08-04 | $2.70M 10-K · filed 2026-02-17 |
| 2025-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $827.00K derived: sum of 2 quarters · filed 2026-08-04 | $3.56M 10-Q · filed 2025-11-04 | $6.53M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.36M 10-Q · filed 2026-08-04 | $5.34M derived: sum of 3 quarters · filed 2026-08-04 | $1.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.73M 10-Q · filed 2026-05-05 | $5.70M derived: sum of 2 quarters · filed 2026-05-05 | $1.76M derived: sum of 3 quarters · filed 2026-05-05 | $11.46M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$963.00K derived: sum of 2 quarters · filed 2026-02-17 | $8.73M derived: sum of 3 quarters · filed 2026-02-17 | $8.28M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.76M derived: sum of 2 quarters · filed 2025-11-04 | $5.30M 10-Q · filed 2025-11-04 | $7.05M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $9.24M 10-Q · filed 2025-08-05 | $10.99M derived: sum of 3 quarters · filed 2026-02-17 | $10.29M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$453.00K 10-Q · filed 2025-05-06 | $1.29M derived: sum of 2 quarters · filed 2026-02-17 | $593.00K derived: sum of 3 quarters · filed 2026-02-17 | $2.19M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.05M derived: sum of 2 quarters · filed 2026-02-17 | $2.65M derived: sum of 3 quarters · filed 2026-02-17 | $2.63M 10-K · filed 2026-02-17 |
| 2023-09-30 | -$699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $902.00K derived: sum of 2 quarters · filed 2024-11-04 | $890.00K 10-Q · filed 2024-11-04 | $1.29M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.59M 10-Q · filed 2024-08-06 | $1.99M derived: sum of 3 quarters · filed 2025-02-18 | $1.54M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | -$12.00K 10-Q · filed 2024-05-07 | $385.00K derived: sum of 2 quarters · filed 2025-02-18 | -$64.00K derived: sum of 3 quarters · filed 2025-02-18 | $989.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$52.00K derived: sum of 2 quarters · filed 2025-02-18 | $1.00M derived: sum of 3 quarters · filed 2025-02-18 | $1.86M 10-K · filed 2025-02-18 |
| 2022-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $604.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.47M 10-Q · filed 2023-11-07 | $1.46M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.92M 10-Q · filed 2023-08-10 | $1.91M derived: sum of 3 quarters · filed 2024-02-20 | $2.29M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $863.00K 10-Q · filed 2023-05-09 | $856.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.23M derived: sum of 3 quarters · filed 2024-02-20 | $1.77M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $370.00K derived: sum of 2 quarters · filed 2024-02-20 | $906.00K derived: sum of 3 quarters · filed 2024-02-20 | $1.17M 10-K · filed 2024-02-20 |
| 2021-09-30 | $377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $913.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.17M 10-Q · filed 2022-11-08 | $714.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $796.00K 10-Q · filed 2022-08-15 | $337.00K derived: sum of 3 quarters · filed 2023-03-07 | $830.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $260.00K 10-Q · filed 2022-05-10 | -$199.00K derived: sum of 2 quarters · filed 2023-03-07 | $294.00K derived: sum of 3 quarters · filed 2023-03-07 | $521.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $34.00K derived: sum of 2 quarters · filed 2023-03-07 | $261.00K derived: sum of 3 quarters · filed 2023-03-07 | $225.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | $493.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $720.00K derived: sum of 2 quarters · filed 2021-11-15 | $684.00K 10-Q · filed 2021-11-15 | $642.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-06-30 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $191.00K 10-Q · filed 2021-08-10 | $149.00K derived: sum of 3 quarters · filed 2022-03-18 | $185.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-03-31 | -$36.00K 10-Q · filed 2021-05-10 | -$78.00K derived: sum of 2 quarters · filed 2022-03-18 | -$42.00K derived: sum of 3 quarters · filed 2022-03-18 | -$473.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2019-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$6.00K derived: sum of 2 quarters · filed 2022-03-18 | -$437.00K derived: sum of 3 quarters · filed 2022-03-18 | -$195.00K 10-K · filed 2022-03-18 |
| 2019-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$395.00K derived: sum of 2 quarters · filed 2020-11-12 | -$153.00K 10-Q · filed 2020-11-12 | -$183.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-06-30 | -$431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$189.00K 10-Q · filed 2020-08-12 | -$219.00K derived: sum of 3 quarters · filed 2021-03-23 | -$367.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-03-31 | $242.00K 10-Q · filed 2020-05-12 | $212.00K derived: sum of 2 quarters · filed 2021-03-23 | $64.00K derived: sum of 3 quarters · filed 2021-03-23 | |
| 2018-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$178.00K derived: sum of 2 quarters · filed 2021-03-23 | $322.00K 10-K · filed 2021-03-23 | |
| 2018-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $352.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $500.00K 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $254.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |